Caring for patients with chronic kidney disease: A joint opinion of the ambulatory care and the nephrology practice and research networks of the American college of clinical pharmacy

被引:24
作者
Zillich, AJ
Saseen, JJ
DeHart, RM
Dumo, P
Grabe, DW
Gilmartin, C
Hachey, DM
Hudson, JQ
Pruchnicki, MC
Joy, MS
机构
[1] Purdue Univ, Sch Pharm, Purdue Pharm Programs, Indianapolis, IN 46202 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, Denver, CO USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Family Med, Denver, CO USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pharm Practice, Denver, CO USA
[5] Samford Univ, McWhorter Sch Pharm, Birmingham, AL USA
[6] Samford Univ, Med Ctr E Family Practice Residency Program, Birmingham, AL USA
[7] Harper Univ Hosp, Dept Pharm, Detroit, MI USA
[8] Albany Coll Pharm, Albany, NY USA
[9] Univ Illinois, Dept Pharm Practice, Chicago, IL USA
[10] Idaho State Univ, Coll Pharm, Dept Pharm Practice, Pocatello, ID USA
[11] Idaho State Univ, Coll Pharm, Dept Family Med, Pocatello, ID USA
[12] Univ Tennessee, Dept Pharm, Memphis, TN USA
[13] Univ Tennessee, Dept Med, Memphis, TN 38104 USA
[14] Ohio State Univ, Coll Pharm, Div Pharm Practice & Adm, Columbus, OH USA
[15] Univ N Carolina, Sch Med, Div Nephrol & Hypertens, Chapel Hill, NC USA
来源
PHARMACOTHERAPY | 2005年 / 25卷 / 01期
关键词
chronic kidney disease; patient care; primary care; pharmacists' role;
D O I
10.1592/phco.25.1.123.55628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An increasing number of patients are developing chronic kidney disease (CKD). Appropriate care for patients with CKD must occur in the earliest stages, preferably before CKD progresses to more severe stages. Therefore, recognition and treatment of CKD and its associated complications must occur in primary care settings. Patients with CKD often have comorbid conditions such as diabetes mellitus, hypertension, and dyslipidemia, creating specific considerations when treating these diseases. Also, these patients have CKD-related conditions, including anemia and renal osteodystrophy, that are not traditionally evaluated and monitored by the primary care practitioner. Collectively, many opportunities exist for pharmacists who practice in the primary care setting to improve the care of patients with CKD.
引用
收藏
页码:123 / 143
页数:21
相关论文
共 131 条
  • [1] ABOSAIF NY, 2004, AM J KIDNEY DIS S, V43, pS1
  • [2] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
  • [3] *AM COLL END, 2002, ENDOCR PRACT S1, V8, pS5
  • [4] American Diabetes Association, 2003, DIABETES CARE S1, V26, pS94
  • [5] American Diabetes Association, 2003, DIABETES CARE S1, V26, pS33, DOI [DOI 10.2337/DIACARE.26.2007.S33, 10.2337/diacare.26.2007.s33]
  • [6] ANDERSEN S, 1999, HYPERTENSION PRIMER, P190
  • [7] [Anonymous], 2001, Am J Kidney Dis, V37, pS182
  • [8] [Anonymous], 1997, MMWR Recomm Rep, V46, P1
  • [9] [Anonymous], 2003, American Medical Journal of Kidney Disease, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3
  • [10] Arday DR, 2003, DIABETES CARE, V26, P972